tetracaine has been researched along with morphine sulfate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Berry, L; Bregman, H; Buchanan, JL; Chen, A; DiMauro, EF; Du, B; Feric, E; Hierl, M; Huang, L; Immke, D; Janosky, B; Johnson, D; Li, X; Ligutti, J; Liu, D; Malmberg, A; Matson, D; McDermott, J; McDonough, SI; Miu, P; Nguyen, HN; Patel, VF; Waldon, D; Wilenkin, B; Zheng, XM; Zou, A | 1 |
2 other study(ies) available for tetracaine and morphine sulfate
| Article | Year |
|---|---|
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Identification of a potent, state-dependent inhibitor of Nav1.7 with oral efficacy in the formalin model of persistent pain.
Topics: Acetamides; Administration, Oral; Analgesics; Animals; Binding Sites; Cell Line; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Formaldehyde; Ganglia, Spinal; Humans; In Vitro Techniques; Microsomes, Liver; NAV1.1 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Neurons; Pain; Pain Measurement; Patch-Clamp Techniques; Rats; Sodium Channel Blockers; Sodium Channels; Solubility; Structure-Activity Relationship; Tetrodotoxin; Triazines | 2011 |